Effect of chronic pretreatment with beta-blockers on no-reflow phenomenon in diabetic patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
Conclusion Chronic pre-treatment with B-blocker in diabetic patients presenting with STEMI, is associated with lower rate of occurrence of no-reflow phenomenon after primary PCI.
Source: The Egyptian Heart Journal - Category: Cardiology Source Type: research
More News: Angioplasty | Arrhythmia | Beta-Blockers | Cardiology | Chronic Pain | Coronary Angioplasty | Diabetes | Endocrinology | Heart | Heart Attack | Pain | Percutaneous Coronary Intervention | Study